Molecular Mechanisms Of Cell Adhesion And Invasion

细胞粘附和侵袭的分子机制

基本信息

项目摘要

Cell adhesion and migration contribute to normal processes such as differentiation, embryonic development, and wound healing as well as to the progression of diseases and pathological conditions that can result from either acute or chronic exposure to environmental toxicants, such as cancer and inflammatory responses. Key mechanistic steps in these processes involve the interactions of extracellular glycoproteins--such as fibronectin, laminin, and collagens--with specific adhesive receptors, the best characterized of which are the integrins, a family of heterodimeric complexes consisting of an alpha subunit and a beta subunit. Integrins are highly regulated receptors that can exist in either an active or inactive state. Selectins are vascular cell-cell adhesion molecules involved in leukocyte trafficking, inflammation, thrombosis, autoimmunity and cancer. Accumulation of leukocytes at sites of inflammation is initiated by selectins that mediate the capturing and rolling of leukocytes on endothelium. Three major members of the selectin family have been identified: L-selectin, E-selectin and P-selectin. L-Selectin is constitutively expressed on leukocytes. P-and E-selectins are expressed on activated endothelial cells in response to microenvirnomental stimuli. P-selectin is also expressed on thrombin-activated platelets. All three members of the selectin family, E-, L-, and P-selectin can bind to human tumor cells and cancer-derived cell line. Our research has focused recently on the possible role of cues from the tumor microenvironment that can regulate integrin-mediated tumor cell migration and invasion. As a model system, we are examining the ability of one selectin, P-selectin, to trigger integrin-mediated adhesion and migration of cultured human tumor cells. We focus on two closely related aspects of this project: to characterize the mechanisms of P-selectin-induced activation of integrin-mediated cell adhesion and cell migration. We have previously shown that binding of soluble, recombinant P-selectin-IgG Fc chimeric protein to Colo-320 cells stimulates cell adhesion to fibronectin through the specific activation of the alpha5-beta1 integrin by means of the p38 MAP kinase and PI-3 kinase (PI3-k) signaling pathways. We have now identified nucleolin as a novel cell surface P-selectin receptor on Colo-320 cells using affinity chromatography and a proteomic approach. We have also found that P-selectin binding to Colo-320 cells induces tyrosine phosphorylation specifically of cell-surface nucleolin and formation of a signaling complex containing cell surface nucleolin, PI 3-K, and p38 MAPK. Using siRNA approaches, we showed that both P-selectin binding to Colo-320 cells and formation of the P-selectin-mediated p38 MAPK/ PI 3-K signaling complex require nucleolin expression. Thus, we have characterized nucleolin (or a nucleolin-like protein) as a novel, signaling cell-surface receptor for P-selectin on Colo-320 cells and suggest a mechanism for linkage of nucleolin to P-selectin-induced signal transduction pathways that regulate the adhesion of Colo-320 on fibronectin substrates. We have recently been characterizing the stimulation of integrin-mediated tumor cell migration by the binding of soluble, recombinant P-selectin-IgG Fc chimeric protein. We have found that P-selectin stimulates the secretion of matrix metalloproteinase-9 (MMP-9) by A375 human melanoma cells and that direct addition of exogenous MMP-9 to A-375 cells can stimulate the migratory phenotype. The current paradigm in the field states that MMP-9 stimulates migration by digesting basement membrane proteins, allowing tumor cells to clear a migratory pathway. However, we have preliminary data that show that stimulation of cell migration by MMP-9 can occur even in the absence of catalytic activity.
细胞粘附和迁移有助于正常过程,例如分化、胚胎发育和伤口愈合,以及由于急性或慢性暴露于环境毒物(例如癌症和炎症反应)而导致的疾病和病理状况的进展。这些过程中的关键机制步骤涉及细胞外糖蛋白(例如纤连蛋白、层粘连蛋白和胶原蛋白)与特定粘附受体的相互作用,其中最具特征的是整合素,这是一个由 α 亚基和 β 亚基组成的异二聚体复合物家族。整合素是高度调控的受体,可以以活性或非活性状态存在。 选择素是血管细胞间粘附分子,参与白细胞运输、炎症、血栓形成、自身免疫和癌症。白细胞在炎症部位的积累是由选择素引发的,选择素介导白细胞在内皮上的捕获和滚动。 已鉴定出选择素家族的三个主要成员:L-选择素、E-选择素和P-选择素。 L-选择素在白细胞上组成型表达。 P-和E-选择素在响应微环境刺激的活化内皮细胞上表达。 P-选择素也在凝血酶激活的血小板上表达。 选择素家族的所有三个成员,E-、L-和P-选择素都可以与人类肿瘤细胞和癌症衍生细胞系结合。 我们的研究最近集中在肿瘤微环境中的线索可能发挥的作用,这些线索可以调节整合素介导的肿瘤细胞迁移和侵袭。作为一个模型系统,我们正在研究一种选择素(P-选择素)触发整合素介导的培养人类肿瘤细胞粘附和迁移的能力。我们重点关注该项目的两个密切相关的方面:表征 P-选择素诱导的整合素介导的细胞粘附和细胞迁移激活的机制。 我们之前已经证明,可溶性重组 P-选择素-IgG Fc 嵌合蛋白与 Colo-320 细胞的结合可通过 p38 MAP 激酶和 PI-3 激酶 (PI3-k) 信号通路特异性激活 α5-β1 整合素,从而刺激细胞与纤连蛋白的粘附。 我们现在使用亲和层析和蛋白质组学方法将核仁素鉴定为 Colo-320 细胞上的新型细胞表面 P-选择素受体。 我们还发现,P-选择素与 Colo-320 细胞结合可诱导细胞表面核蛋白特异性酪氨酸磷酸化,并形成含有细胞表面核蛋白、PI 3-K 和 p38 MAPK 的信号复合物。 使用 siRNA 方法,我们发现 P-选择素与 Colo-320 细胞的结合以及 P-选择素介导的 p38 MAPK/PI 3-K 信号复合物的形成都需要核仁素的表达。因此,我们将核仁素(或核仁素样蛋白)描述为 Colo-320 细胞上 P-选择素的新型信号传导细胞表面受体,并提出了核仁素与 P-选择素诱导的信号转导途径的连接机制,该途径调节 Colo-320 在纤连蛋白基质上的粘附。 我们最近一直在研究通过可溶性重组 P-选择素-IgG Fc 嵌合蛋白的结合来刺激整合素介导的肿瘤细胞迁移。 我们发现P-选择素刺激A375人黑色素瘤细胞分泌基质金属蛋白酶9(MMP-9),并且直接向A-375细胞添加外源MMP-9可以刺激迁移表型。 该领域当前的范例表明,MMP-9 通过消化基底膜蛋白来刺激迁移,从而使肿瘤细胞能够清除迁移途径。 然而,我们的初步数据表明,即使在没有催化活性的情况下,MMP-9 也会刺激细胞迁移。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Akiyama其他文献

Steven Akiyama的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Akiyama', 18)}}的其他基金

Molecular Mechanisms Of Cell Adhesion And Invasion
细胞粘附和侵袭的分子机制
  • 批准号:
    7967969
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
DNA Sequencing
DNA测序
  • 批准号:
    8149655
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
Molecular Mechanisms Of Cell Adhesion And Invasion
细胞粘附和侵袭的分子机制
  • 批准号:
    8148988
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
Molecular Mechanisms Of Cell Adhesion And Invasion
细胞粘附和侵袭的分子机制
  • 批准号:
    8553682
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
Molecular Mechanisms Of Cell Adhesion And Invasion
细胞粘附和侵袭的分子机制
  • 批准号:
    8734055
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
DNA Sequencing
DNA测序
  • 批准号:
    8336682
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
DNA Sequencing
DNA测序
  • 批准号:
    7969880
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:
DNA Sequencing
DNA测序
  • 批准号:
    7734579
  • 财政年份:
  • 资助金额:
    $ 182.32万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 182.32万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了